Tadalafil for erectile dysfunction: excellent safety and tolerance / 中华男科学杂志
National Journal of Andrology
;
(12): 92-95, 2009.
Artículo
en Chino
| WPRIM
| ID: wpr-292418
ABSTRACT
As a novel phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally for the treatment of erectile dysfunction (ED). In addition to its outstanding efficacy that lasts 36 hours, tadalafil shows an excellent safety and tolerance, with only a few transient mild to moderate adverse events. Usually ED patients are concomitantly afflicted with multiple pre-existing medical conditions or receive a range of drugs at the same time. Therefore, it is essential to understand its safety in general population and some special high-risk cohorts.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Inhibidores de Fosfodiesterasa
/
Carbolinas
/
Usos Terapéuticos
/
Quimioterapia
/
Tolerancia a Medicamentos
/
Tadalafilo
/
Disfunción Eréctil
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS